Topic archive

eli lilly

3 stories

10/28/2026

Pharma giants invest billions in psychedelics despite hurdles

Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.

8/8/2026

AtaiBeckley and Compass Pathways explore new opportunities.

7/17/2026

Pharmaceutical giant expands into psychedelic research with major acquisition.